It is assumed that DNMT3A mutations are acquired months or years before a potential onset of AML from hematopoietic stem cells or multipotent precursor cells leading to a pre-leukemic state that potentially leads to the development of AML26,27. This evidence concerns the gene DNMT3A and acute myeloid leukemia.